Impaired skeletal muscle mitochondrial pyruvate uptake rewires glucose metabolism to drive whole-body leanness

Metabolic cycles are a fundamental element of cellular and organismal function. Among the most critical in higher organisms is the Cori Cycle, the systemic cycling between lactate and glucose. Here, skeletal muscle-specific Mitochondrial Pyruvate Carrier (MPC) deletion in mice diverted pyruvate into circulating lactate. This switch disinhibited muscle fatty acid oxidation and drove Cori Cycling that contributed to increased energy expenditure. Loss of muscle MPC activity led to strikingly decreased adiposity with complete muscle mass and strength retention. Notably, despite decreasing muscle glucose oxidation, muscle MPC disruption increased muscle glucose uptake and whole-body insulin sensitivity. Furthermore, chronic and acute muscle MPC deletion accelerated fat mass loss on a normal diet after high fat diet-induced obesity. Our results illuminate the role of the skeletal muscle MPC as a whole-body carbon flux control point. They highlight the potential utility of modulating muscle pyruvate utilization to ameliorate obesity and type 2 diabetes.

[1]  E. Taylor,et al.  Two human patient mitochondrial pyruvate carrier mutations reveal distinct molecular mechanisms of dysfunction. , 2019, JCI insight.

[2]  Liping Yu,et al.  Oxaloacetic acid mediates ADP-dependent inhibition of mitochondrial complex II–driven respiration , 2018, The Journal of Biological Chemistry.

[3]  L. Quek,et al.  Acute activation of pyruvate dehydrogenase increases glucose oxidation in muscle without changing glucose uptake. , 2018, American journal of physiology. Endocrinology and metabolism.

[4]  J. Colca,et al.  MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis , 2018, Expert opinion on investigational drugs.

[5]  G. Brooks.  The Science and Translation of Lactate Shuttle Theory. , 2018, Cell metabolism.

[6]  Joshua D. Rabinowitz,et al.  Glucose feeds the TCA cycle via circulating lactate , 2017, Nature.

[7]  Matthew J. Potthoff,et al.  Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting , 2017, Molecular metabolism.

[8]  Matthew J. Potthoff,et al.  OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance , 2017, The EMBO journal.

[9]  H. Kern,et al.  Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence , 2017, Cell metabolism.

[10]  J. Schaffer,et al.  Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis , 2017, Hepatology.

[11]  Dean Y. Li,et al.  Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart , 2016, JACC. Basic to translational science.

[12]  Caitlyn E. Bowman,et al.  Requirement for the Mitochondrial Pyruvate Carrier in Mammalian Development Revealed by a Hypomorphic Allelic Series , 2016, Molecular and Cellular Biology.

[13]  E. Taylor,et al.  A Method for Multiplexed Measurement of Mitochondrial Pyruvate Carrier Activity* , 2016, The Journal of Biological Chemistry.

[14]  G. Shulman,et al.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. , 2016, The Journal of clinical investigation.

[15]  A. Voigt,et al.  Skeletal muscle mitochondrial uncoupling prevents diabetes but not obesity in NZO mice, a model for polygenic diabesity , 2015, Genes & Nutrition.

[16]  J. Rutter,et al.  Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis. , 2015, Cell metabolism.

[17]  J. Colca,et al.  Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling. , 2015, Cell metabolism.

[18]  N. Jeoung.  Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers , 2015, Diabetes & metabolism journal.

[19]  Simon Kasif,et al.  Metabolic modeling of muscle metabolism identifies key reactions linked to insulin resistance phenotypes , 2015, Molecular metabolism.

[20]  L. Goodyear,et al.  Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. , 2014, Advances in physiology education.

[21]  R. Deberardinis,et al.  Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. , 2014, Molecular cell.

[22]  Christian M. Metallo,et al.  Regulation of substrate utilization by the mitochondrial pyruvate carrier. , 2014, Molecular cell.

[23]  G. Shulman,et al.  Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance , 2014, Proceedings of the National Academy of Sciences.

[24]  K. Højlund,et al.  Human Muscle Fiber Type–Specific Insulin Signaling: Impact of Obesity and Type 2 Diabetes , 2014, Diabetes.

[25]  Steven D. Kunkel,et al.  Systems-based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy* , 2014, The Journal of Biological Chemistry.

[26]  Long-Sheng Song,et al.  Sarcolemmal ATP-sensitive potassium channels modulate skeletal muscle function under low-intensity workloads , 2014, The Journal of general physiology.

[27]  E. Taylor,et al.  Regulation of pyruvate metabolism and human disease , 2013, Cellular and Molecular Life Sciences.

[28]  D. McClain,et al.  MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity , 2012, Nature Medicine.

[29]  Claire Redin,et al.  A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans , 2012, Science.

[30]  J. Veuthey,et al.  Identification and Functional Expression of the Mitochondrial Pyruvate Carrier , 2012, Science.

[31]  K. Esser,et al.  Inducible Cre transgenic mouse strain for skeletal muscle-specific gene targeting , 2012, Skeletal Muscle.

[32]  J. W. Dietrich,et al.  The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes , 2012, Diabetologia.

[33]  N. Møller,et al.  GLUT4 and UBC9 Protein Expression Is Reduced in Muscle from Type 2 Diabetic Patients with Severe Insulin Resistance , 2011, PloS one.

[34]  M. Brand,et al.  High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria , 2011, PloS one.

[35]  F. Andrade,et al.  Mitochondrial isolation from skeletal muscle. , 2011, Journal of visualized experiments : JoVE.

[36]  R. Grange,et al.  The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice. , 2011, Journal of applied physiology.

[37]  Oliver T. Bruns,et al.  Brown adipose tissue activity controls triglyceride clearance , 2011, Nature Medicine.

[38]  R. DeFronzo,et al.  Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes , 2009, Diabetes Care.

[39]  M. Tisdale.  Mechanisms of cancer cachexia. , 2009, Physiological reviews.

[40]  Michael A. Via,et al.  Excess thyroid hormone and carbohydrate metabolism. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[41]  P. Neufer,et al.  PDH-E1alpha dephosphorylation and activation in human skeletal muscle during exercise: effect of intralipid infusion. , 2006, Diabetes.

[42]  A. Nordheim,et al.  Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Lyonnet,et al.  Impaired mitochondrial pyruvate importation in a patient and a fetus at risk. , 2003, Molecular genetics and metabolism.

[44]  K. M. Popov,et al.  Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. , 1999, Diabetes.

[45]  J. Simoneau,et al.  Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. , 1997, Journal of applied physiology.

[46]  A. Vaag,et al.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM , 1995, Diabetologia.

[47]  J. Faulkner,et al.  Contractile properties of skeletal muscles from young, adult and aged mice. , 1988, The Journal of physiology.

[48]  S. Lillioja,et al.  Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction , 1988, Diabetes.

[49]  M. Huang,et al.  Effects of thyroid states on the Cori cycle, glucose--alanine cycle, and futile cycling of glucose metabolism in rats. , 1981, Archives of biochemistry and biophysics.

[50]  N. Vesth,et al.  [Evaluation of a cancer screening test (ICP test)]. , 1979, Ugeskrift for laeger.

[51]  J. McGarry,et al.  Hepatic malonyl-CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic assay. , 1978, The Journal of biological chemistry.

[52]  H. Thelander.  On Multiple Defects , 1976 .

[53]  J. Passonneau,et al.  A comparison of three methods of glycogen measurement in tissues. , 1974, Analytical biochemistry.

[54]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[55]  R. Steele,et al.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.

[56]  Matthew J. Potthoff,et al.  OPA 1 deficiency promotes secretion of FGF 21 from muscle that prevents obesity and insulin resistance , 2017 .

[57]  L. Goodyear,et al.  regulating glucose uptake in skeletal muscle Exercise and type 2 diabetes: molecular mechanisms , 2015 .

[58]  J. Rutter.  Mitochondrial pyruvate carrier , 2014 .

[59]  Olga Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[60]  P. J. Randle,et al.  The glucose-fatty-acid cycle. , 1963, Lancet.